Copy
April 2018
 
french La semaine prochaine, nous serons présents à In Cosmetics Global à Amsterdam du 17 avril au 19 avril 2018. Dans cet événement, nous vous ferons découvrir notre laboratoire en réalité virtuelle et nous vous présenterons un large panel de services in vitro et d'imagerie cellulaire dédiés à l'industrie dermo-cosmétique. Nous avons développé différents modèles tels que anti-aging, wound healing et anti inflammation. De plus, vous pourrez découvrir notre toute nouvelle technologie BIOMIMESYS® pour la culture cellulaire 3D. Il s'agit d'un "hydroscaffold" unique et naturel basé sur l'acide hyaluronique, biofonctionnalisé avec d'autres composants de la matrice extracellulaire (comme les collagènes).
Voulez-vous en savoir plus? Rencontrez Pierre-Jean (Responsable Cosmétique) ou Leo (Business Developer) en utilisant l'outil de networking de l'événement (My Event) ou en nous contactant pour organiser un rendez-vous !
A bientôt à Amsterdam!
 
english Next week, we will be attending to In Cosmetics Global in Amsterdam from the 17th April to the 19th April 2018. In this event we will let you discover our lab in virtual reality and allow you to discover a large panel of In Vitro and Cellular Imaging services dedicated to the dermocosmetic Industry. We have developed different model such as anti-aging, wound healing and anti inflammation. Furthermore, you will be able to discover our brand new BIOMIMESYS® technology for 3D cell culture. This is an unique and natural hydroscaffold based on hyaluronic acid, biofunctionalized with other extracellular matrix components (like collagens).
Do you want to know more? Meet Pierre-Jean (Team Leader) or Leo (Business Developer) using  the networking tool of the event (My Event) or just contact us to set up a meeting!
See you soon in Amsterdam!
 
 

Predicting clinical outcomes of wound healing assessment : the limitations of the mice model

Wounds can exhibit impaired healing, as a consequence of pathologic failure to process one of the normal stage of healing. Wound healing impairment could be characteristic of the treatments of chronic wounds due to immobilisation, diabetes, and skin infection. 

Europe is celebrating the fifth year without cosmeting testing on animals

Originally, cosmetics were tested on animals, but since a couple of year’s manufacturer have tried to avoid this test to match the new regulation on animal testing.

Could the microbiota be the solution to all our health problem?

Microbiota is the community of the symbiotic and pathogenic microorganism that we would find in our intestine or on our skin. Today there is more and more researcher in Pharma or Dermocosmetology who are working on microbiota to find solution to treat different disease link to the inflammation and auto immunity diseases.

Mimicking the fat cell microenvironment in vitro

Adipose tissue is vitally important to various normal processes of the human body, and it has also many implications for human disease states. Obesity is a common health problem and is considered as a major risk factor for non insulin-dependent diabetes mellitus, cardiovascular diseases and hypertension. 

To be genotoxic, or not? That is the question!

Distinguishing aneugenic (chromosomes loss) from clastogenic effects (DNA damages) is essential to assess genotoxic properties of compounds.

The BIOMIMESYS® website is now open and you can easily find information about this technology, different products (Liver and Adipose tissue) and useful tips to use it. If you need more or if you wonder how BIOMIMESYS® can be used in your assays, just ask!

Adipose tissue

Adipose tissue

Adipose tissue

Scientific posters 2017

Urine sample-derived human induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemia

Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) technology

In vitro dermocosmetology : high content analysis approach using human primary keratinocytes and fibroblasts
 

Services

Explain us your requirements and we develop your assays to best meet your needs !

Accueil_oncology

Dermocosmetology

Toxicology

Pharmacology

Why HCS ?

To target complex diseases (as cancer and neurodegenerative diseases), more than one target are needed and screening on complex model is recommended.

View this email in your browser
Website
Website
LinkedIn
LinkedIn
Twitter
Twitter
Google Plus
Google Plus
Contact Us
Contact Us
Copyright © 2018 HCS Pharma, All rights reserved.

Our mailing address is:
HCS Pharma
250 rue Salvador Allende
Batiment A
LOOS 59120
France

Add us to your address book


unsubscribe from this list    update subscription preferences 

Email Marketing Powered by Mailchimp